PLURISTEM LTD. - Israel 

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:500-600
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2011-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 6
As coordinator: 0
As participant: 6
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 7.447.875 0 1
2019 0 1.000.000 15.000 1
2018 0 7.437.128 2.548.075 1
2017 0 14.459.580 3.564.250 2
2011 0 11.971.721 92.955 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
CHARITE UNIVERSITAETSMEDIZIN BERLIN4
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA2
ICON CLINICAL RESEARCH LIMITED2
INNOVATION ACTA2
ACONDICIONAMIENTO TARRASENSE ASSOCIACION1
ASKLEPIOS KLINIKEN HAMBURG1
ASPHALION SL1
BAR ILAN UNIVERSITY1
BE THE PARTNER1
BE THE PARTNER INC1
CAMBRIDGE NANOMATERIALS TECHNOLOGY1
CELL THERAPY CATAPULT LIMITED1
DIGNA BIOTECH SL1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
FONDATION TRANSPLANTATION1
FONDAZIONE POLIAMBULANZA1
FONDAZIONE TELETHON1
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA1
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA1
GENOME IDENTIFICATION DIAGNOSTICS1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INTERNATIONAL OSTEOPOROSIS FOUNDATION1
MILTENYI BIOTEC1
MILTENYI BIOTEC BV & CO KG1
MJR PHARMJET1
NATIONAL CENTER FOR SCIENTIFIC RESEARCH ""DEMOKRITOS""1
OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST1
OXI GEN LAB1
PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG PRIVATSTIFTUNG1
REGION SYDDANMARK1
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU1
RUHR UNIVERSITAET BOCHUM1
STICHTING VU1
TECHNISCHE UNIVERSITAET DRESDEN1
TEXNOLOGIKES LYSEIS BIOEKPOMPIS OE1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
TISSUSE1
UNIVERSIDADE DO MINHO1
UNIVERSIDADE DO PORTO1
UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO1
UNIVERSITA DEGLI STUDI DI BRESCIA1
UNIVERSITA DEGLI STUDI DI PERUGIA1
UNIVERSITAET ZUERICH1
UNIVERSITAETSKLINIKUM HEIDELBERG1
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ1
UNIVERSITEIT ANTWERPEN1
UNIVERSITEIT MAASTRICHT1
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN1
UNIVERSITY OF DEBRECEN1
UNIVERSITY OF OSLO1
UNIVERSITY OF WALES CARDIFF1
VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG1
VIVOTECNIA RESEARCH SL1

Constancy:

Total number of partners: 59
Partner loyalty:
Frequent Partner: (> 2 projects): 4
Rare Partner: 55
Frequent / Rare Partner Ratio: 0.07

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01PROTO - Advanced PeRsOnalized Therapies for Osteoarthritis – TACKLING INFLAMMATION TO IMPROVE PATIENT OUTCOMES PROTOparticipant7.447.87510
2019-03-01RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients RESTOREparticipant1.000.00011
2018-01-01Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicenter phase III trial HIPGENparticipant7.437.12812
2017-10-01Multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regeneration nTRACKparticipant6.863.86512
2017-01-01A multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies PACEparticipant7.595.7158
2011-01-01The MEtabolic Road to DIAstolic Heart Failure MEDIAparticipant11.971.72121

Alias institution names:

  • PLURI BIOTECH
  • PLURISTEM